Menstrual Cycle Cycle Disorders

Uterine bleeding: how understanding endometrial physiology underpins menstrual health

Jain V, Chodankar RR, Maybin JA, Critchley HOD

Published May 2022 Nature reviews. Endocrinology, 18(5), 290-308
DOI 10.1038/s41574-021-00629-4 PMID 35136207 PMC PMC9098793

RRM Academy Synopsis

An imbalance in one endometrial process can lead to abnormal bleeding

A 2022 narrative review finds that an imbalance in any one endometrial process can lead to abnormal uterine bleeding, and a systematic assessment can identify the cause or causes. Up to one third of women worldwide may be affected. The authors also ask whether current treatments address the underlying cause.

Key Findings

  • Up to one third of women worldwide are estimated to experience abnormal uterine bleeding (AUB) at some point during their reproductive years.
  • About 30% of women with AUB worldwide are anemic. The share is approximately 60% in South Asia, Africa and the eastern Mediterranean.
  • FIGO's PALM-COEIN system names nine cause categories. Four are structural (Polyp, Adenomyosis, Leiomyoma, Malignancy) and four are non-structural, plus one for causes not otherwise classified.
  • A national UK audit of heavy menstrual bleeding care found most treatments targeted the bleeding itself. One third of the women felt they needed a hysterectomy.
  • One in five women on progestin-only treatments might have unscheduled bleeding.

Interpretation

The paper is a narrative review. Experts summarize published work without a systematic search or pooled analysis. Several mechanisms it describes come from mouse and non-human primate models of menstruation. The authors limit their scope to non-malignant bleeding. They report that no new treatments for heavy bleeding have reached routine use in 20 years.

RRM Context

The review calls for finding the cause of heavy bleeding and tailoring care to each patient. Its authors write that suppressing ovarian hormones offers no panacea. They add that hormone-based therapies could add to the load of fibroids or adenomyosis. Cause-first evaluation is a core restorative reproductive medicine principle.

Abstract

Menstruation is a physiological process that is typically uncomplicated. However, up to one third of women globally will be affected by abnormal uterine bleeding (AUB) at some point in their reproductive years. Menstruation (that is, endometrial shedding) is a fine balance between proliferation, decidualization, inflammation, hypoxia, apoptosis, haemostasis, vasoconstriction and, finally, repair and regeneration. An imbalance in any one of these processes can lead to the abnormal endometrial phenotype of AUB. Poor menstrual health has a negative impact on a person's physical, mental, social, emotional and financial well-being. On a global scale, iron deficiency and iron deficiency anaemia are closely linked with AUB, and are often under-reported and under-recognized. The International Federation of Gynecology and Obstetrics have produced standardized terminology and a classification system for the causes of AUB. This standardization will facilitate future research endeavours, diagnosis and clinical management. In a field where no new medications have been developed for over 20 years, emerging technologies are paving the way for a deeper understanding of the biology of the endometrium in health and disease, as well as opening up novel diagnostic and management avenues.

Topics

By this author

Related research

Menstrual Cycle › Cycle Disorders › Abnormal Uterine Bleeding
Varsha Jain, Rohan R Chodankar, Jacqueline A Maybin, Hilary O D Critchley
V Jain, R Chodankar, J Maybin, H Critchley
PMID 35136207 35136207 DOI 10.1038/s41574-021-00629-4 10.1038/s41574-021-00629-4 Jain et al. 2022, Jain 2022